Study reveals dramatic rise in ivermectin and hydroxychloroquine prescriptions during COVID-19

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their effectiveness, new UCLA-led research shows.

Continue ReadingStudy reveals dramatic rise in ivermectin and hydroxychloroquine prescriptions during COVID-19

New clinical trial seeks alternatives for head and neck cancer patients unable to use cisplatin

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug…

Continue ReadingNew clinical trial seeks alternatives for head and neck cancer patients unable to use cisplatin